SMS alerts can make the difference between a profitable trade and a missed opportunity.
 Text “MOMO” to 555888 to receive our instant, reliable and free SMS alerts.

Good morning all,

PSID jumped higher out of the gate, opening at $0.005 and hitting a morning high of $0.0062, for 20%+ potential gains.

Unfortunately the momentum couldn't carry it higher - not yet anyway. It pulled back to $0.0042 before bouncing back green to $0.0055 for 17% potential gains, which is where we sit as I write this email.

So, its been a wild swing so far today, but gains have been made - either at the open, or on the pullback and subsequent bounce higher.

I urge you to keep PSID on your radar. The technical's are suggesting an oversold bounce could be coming, either today or in the very near future.

Given PSID's history of making some epic short term gains, you may want to be positioned accordingly.

All the best.

SmallCapMomo.com


----------------------------------------------------------------------------------------------


Traders and Investors,

I've got a low float, small market cap trade idea to focus on today. It's a past winner we have alerted a few times to you in the past year.

And this time, with an RSI of only 33, it appears to be drastically oversold - and could be due for a bounce.
 
It's time to get PositiveID Corp (PSID) on your screen once again.

PSID looks ready to bounce... now. It has been in a slow and steady downtrend for many months now, closing at $0.005 on Friday , after it was trading well above $0.04 just a couple months ago, and up around over $0.10 level back in June.

PSID has a long history of making some big short term moves. Back in September it gained over 200% in a few days. And in July it gained over 120% in one day.

It seems almost every month PSID has a period of making a sharp move to the upside. Except October and November to date - which makes me think PSID could be well overdue for a run higher.

With PSID trading at $0.005 after an aggressive sell off in recent days, and with such a tiny market cap and float of around $600k, we could potentially see a big bounce higher to come in the near term.

And let's address the elephant in the room - those short sellers. If there is some upside momentum in PSID, shorts may be scrambling to cover their positions - which could cause a major short squeeze.


 
PSID is no stranger to positive news.  The company has been releasing a lot of big news recently which should get investors excited about the future.

Back in June PSID closed a $1.5 million investment, and the Company recently reported their Q3 results highlighted by the 152% increase in Company's E-N-G Mobile Systems (“ENG”) subsidiary year-to-date vehicle bookings over the the first nine months of 2016; this increase was driven by bookings during the third quarter of more than $1.5 million. 

Back in August PSID announced their Q2 results which recorded some massive highlights, including: 

• Revenue for the first six-months of 2017 increased 20% over the second half of 2016
   
• Gross margin continued to improve, increasing to 39% for the quarter ended June 30, 2017, up from 35% for the first quarter of 2017, and 32% for the quarter ended December 31, 2016
   
• Sales of the Caregiver non-contact thermometer for the quarter ended June 30, 2017 increased 82% from the quarter ended March 31, 2017, and 121% from the quarter ended June 30, 2016, as reported in the Companys Form 10-Q
   
• Company expects full year 2017 revenue to exceed 2016 revenue of $5.6 million

PositiveID Corp (PSID) is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays.

PSID operates in three segments: Mobile Labs, comprised of its E-N-G Mobile Systems (“ENG”) subsidiary; Medical Devices, comprised of its Thermomedics subsidiary; and Molecular Diagnostics, consisting of its Firefly Dx prototype system for real-time pathogen detection.

ENG designs and builds mobile laboratories, wireless support vehicles (cell-on-wheels and cell-on-light-trucks), radio frequency (“RF”) test platforms, broadcast news vehicles, and other technical vehicles. ​ENG has delivered more than 1,500 specialty vehicles to customers around the globe, including more than 400 mobile laboratories, 600 broadcast news vehicles, and more than 400 vehicles for cellular, RF, infrared, and other applications.

Thermomedics markets the FDA-cleared Caregiver® thermometer, which is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs.

PSID is developing the Firefly Dx prototype system to be a handheld, fully automated, lab quality, real-time device able to detect pathogens at the point of need, faster and less expensively than existing devices. Firefly's applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.

The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins.

PositiveID's Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time polymerase chain reaction (PCR) chemistry. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets by enabling hospitals, physicians and other providers to save lives and fight disease.

You can learn more about PSID at their website http://www.psidcorp.com/


According to OTCMarkets.com, PSID has a tiny market cap of around $600k and the company just recently announced strong financial performance.

PSID has a technically oversold chart, which if history is anything to go by, we think could be ready to bounce significantly higher in the short term. In fact, we believe based on the technical indicators and news catalysts, PSID could be a major gainer in the coming days/weeks.

Make sure you do your DD on PSID and be ready to play today.

 

 

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.